Get the Stockscreener App
39.49
0.60%
-0.24
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $39.49, with a volume of 750.55K.
It is down -0.60% in the last 24 hours and down -7.13% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
See More
Previous Close:
$39.73
Open:
$40.01
24h Volume:
750.55K
Relative Volume:
0.64
Market Cap:
$2.10B
Revenue:
$238.11M
Net Income/Loss:
$-31.45M
P/E Ratio:
-62.35
EPS:
-0.6334
Net Cash Flow:
$7.66M
1W Performance:
-0.90%
1M Performance:
-7.13%
6M Performance:
+20.29%
1Y Performance:
+198.94%
1-Day Range:
$39.35
$40.65
1-Week Range:
$38.38
$40.87
52-Week Range:
$12.38
$46.95
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
39.49 | 2.10B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
103.06 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.25 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.21 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
44.25 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.63 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Wells Fargo | Overweight |
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
AXGN|AxoGen Inc|Price:39.490|Chg%:-0.240 - TradingKey
Axogen Inc. (AXGN) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock Edges LowerROIC Trend Report - dars.gov.et
Does NZS Capital’s ‘Optionality’ Stake and Coverage Momentum Change The Bull Case For Axogen (AXGN)? - simplywall.st
NZS Capital Added Axogen (AXGN) as an Optionality Position - Yahoo Finance
(AXGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 - Sahm
Axogen to report Q2 2026 financial results on J... - Pluang
Axogen schedules investor webcast after July 29 results - Stock Titan
Axogen Insiders Sold US$6.2m Of Shares Suggesting Hesitancy - Moomoo
What Axogen (AXGN)'s Russell Index Removal Means For Shareholders - simplywall.st
AXGN Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesNet Profit Margin - dars.gov.et
Axogen Inc. (AXGN) Q1 2026 Earnings: Narrow EPS Miss and Positive Stock Reaction Signal Cautious Optimism - dars.gov.et
Axogen stock hits 52-week high at 46.05 USD - Investing.com UK
Axogen stock hits 52-week high at 46.05 USD By Investing.com - Investing.com Nigeria
Will Axogen’s (AXGN) Russell Index Removal Reshape Its Liquidity Profile and Risk‑Reward Narrative? - Sahm
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell Microcap Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Price to earnings forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Daily Brief Health Care: AxoGen Inc, Dentsply International and more - Smartkarma
Axogen Inc. (AXGN) Edges Higher as Shares Test Key Resistance at $47.18Wyckoff Distribution - dars.gov.et
Form 4 Axogen Inc For: 26 June By Investing.com - Investing.com Nigeria
AXGN News | AXOGEN INC (NASDAQ:AXGN) - ChartMill
Axogen (AXGN) director receives 4,392 restricted stock units in annual equity grant - Stock Titan
Axogen (AXGN) director Alan Levine granted 4,392 RSUs valued at $185K - Stock Titan
Axogen (AXGN) director receives 4,392 RSUs in $185,000 equity grant - Stock Titan
Axogen (AXGN) director Wendell McBride awarded 4,392 RSUs valued at $185,000 - Stock Titan
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
Q1 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
AxoGen | 4: Statement of changes in beneficial ownership of securities-Director Burke William P. Mr. - Moomoo
Form DEF 14A Axogen Inc For: 25 June By Investing.com - Investing.com Nigeria
Price to earnings forward of Axogen, Inc. – FWB:LT3 - TradingView
Axogen, Inc. Actuals & Estimates (NASDAQ:AXGN) - TradingView
Enterprise value to revenue forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
AXGN Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Enterprise value to EBITDA forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Price to sales forward of Axogen, Inc. – FWB:LT3 - TradingView
Price to book forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Responsive Playbooks and the AXGN Inflection - Stock Traders Daily
Axogen Inc. (AXGN) Q1 2026 Earnings: EPS Miss Sends Shares Lower Despite Operational ProgressCapex Guidance - dars.gov.et
Form 4 Axogen Inc For: 23 June By Investing.com - Investing.com Australia
Form 8K Axogen Inc For: 23 June By Investing.com - Investing.com India
Axogen shareholders elect board members and approve auditor at annual meeting By Investing.com - Investing.com South Africa
Axogen shareholders elect board members and approve auditor at annual meeting - Investing.com Australia
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.90%
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):